{"preliminary_commentary":{"by_channel":{"x_thread":2,"bluesky_thread":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"NCT04161755","nct_id":"NCT04161755","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct04161755. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Radiologically resectable primary pancreatic tumors","label":"Pancreatic Cancer","type":"EXPERIMENTAL"}],"collaborators":["Genentech, Inc.","Massachusetts Institute of Technology"],"completion_date":{"date":"2026-11-11","type":"ESTIMATED"},"conditions":["Pancreatic Cancer"],"enrollment":{"count":29,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Atezolizumab","otherNames":[],"type":"DRUG"},{"name":"RO7198457","otherNames":[],"type":"BIOLOGICAL"},{"name":"mFOLFIRINOX","otherNames":[],"type":"DRUG"}],"last_update":"2026-01-07","lead_sponsor":"Memorial Sloan Kettering Cancer Center","official_title":"Phase 1 Clinical Trial of Personalized Neoantigen Tumor Vaccines and Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Surgically Resected Pancreatic Cancer","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE1"],"primary_completion_date":{"date":"2026-11-11","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Drug related toxicity","timeFrame":"2 years"}],"references":[],"start_date":{"date":"2019-12-13","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery","url":"https://clinicaltrials.gov/study/NCT04161755"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct04161755"}